| drug metabolic process | GO:0017144 | 4 | 0.840 | |
| oxidation reduction process | GO:0055114 | 342 | 0.793 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.644 | |
| benzene containing compound metabolic process | GO:0042537 | 5 | 0.637 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.568 | Human |
| short chain fatty acid catabolic process | GO:0019626 | 2 | 0.440 | |
| naphthalene containing compound metabolic process | GO:0090420 | 1 | 0.360 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.332 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.304 | |
| blood circulation | GO:0008015 | 195 | 0.290 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.256 | |
| drug catabolic process | GO:0042737 | 2 | 0.255 | Mouse |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.250 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.238 | |
| regulation of estrogen secretion | GO:2000861 | 1 | 0.234 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.229 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.200 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.193 | |
| sulfate assimilation | GO:0000103 | 3 | 0.193 | |
| calcitriol biosynthetic process from calciol | GO:0036378 | 3 | 0.191 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.183 | |
| cellular response to cadmium ion | GO:0071276 | 3 | 0.181 | |
| response to acid chemical | GO:0001101 | 111 | 0.181 | |
| naphthalene metabolic process | GO:0018931 | 1 | 0.179 | |
| response to nitrosative stress | GO:0051409 | 1 | 0.165 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.159 | |
| urogenital system development | GO:0001655 | 261 | 0.148 | |
| lipid localization | GO:0010876 | 126 | 0.144 | |
| amine metabolic process | GO:0009308 | 45 | 0.136 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.131 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.120 | |
| toxin catabolic process | GO:0009407 | 1 | 0.116 | |
| circulatory system process | GO:0003013 | 197 | 0.110 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.110 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.106 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.104 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.104 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.103 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.096 | |
| camera type eye development | GO:0043010 | 266 | 0.096 | |
| nadph regeneration | GO:0006740 | 2 | 0.094 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.091 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.086 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.084 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.081 | |
| renal system development | GO:0072001 | 225 | 0.081 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.081 | |
| steroid metabolic process | GO:0008202 | 119 | 0.079 | |
| lipid catabolic process | GO:0016042 | 69 | 0.079 | |
| acetate metabolic process | GO:0006083 | 1 | 0.077 | |
| hormone metabolic process | GO:0042445 | 86 | 0.077 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.076 | |
| renal tubular secretion | GO:0097254 | 2 | 0.075 | |
| renal system process | GO:0003014 | 48 | 0.074 | |
| acetylcholine catabolic process | GO:0006581 | 1 | 0.074 | |
| response to steroid hormone | GO:0048545 | 56 | 0.072 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.072 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.071 | |
| ethanol metabolic process | GO:0006067 | 3 | 0.070 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.070 | |
| response to testosterone | GO:0033574 | 3 | 0.070 | |
| heart trabecula formation | GO:0060347 | 14 | 0.069 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.067 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.067 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.067 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.066 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.065 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.065 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.065 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.064 | |
| angiogenesis | GO:0001525 | 201 | 0.063 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.063 | |
| vitamin d3 metabolic process | GO:0070640 | 3 | 0.061 | |
| cell adhesion | GO:0007155 | 329 | 0.061 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.060 | |
| response to alcohol | GO:0097305 | 48 | 0.060 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.060 | Human |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.060 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.059 | |
| secondary alcohol metabolic process | GO:1902652 | 3 | 0.058 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.058 | |
| negative regulation of complement activation | GO:0045916 | 3 | 0.057 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.057 | |
| nadp metabolic process | GO:0006739 | 6 | 0.056 | Human |
| retina development in camera type eye | GO:0060041 | 119 | 0.055 | |
| negative regulation of protein activation cascade | GO:2000258 | 3 | 0.054 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.054 | |
| nephron development | GO:0072006 | 109 | 0.053 | |
| heart morphogenesis | GO:0003007 | 178 | 0.051 | |
| skeletal system development | GO:0001501 | 356 | 0.050 | |
| epithelial cell migration | GO:0010631 | 63 | 0.050 | |
| oxidoreduction coenzyme metabolic process | GO:0006733 | 16 | 0.050 | Human |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.049 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.049 | Human |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.048 | |
| cellular response to lipid | GO:0071396 | 145 | 0.048 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.047 | |
| axonogenesis | GO:0007409 | 274 | 0.047 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.047 | |
| unsaturated fatty acid metabolic process | GO:0033559 | 31 | 0.046 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.045 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.044 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.044 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.043 | |
| kidney epithelium development | GO:0072073 | 121 | 0.043 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.043 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.042 | Rat |
| phospholipid metabolic process | GO:0006644 | 87 | 0.042 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.042 | |
| xenobiotic catabolic process | GO:0042178 | 1 | 0.042 | |
| porphyrin containing compound metabolic process | GO:0006778 | 22 | 0.041 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.041 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.040 | |
| regulation of secretion | GO:0051046 | 274 | 0.040 | |
| hexose metabolic process | GO:0019318 | 98 | 0.039 | |
| response to xenobiotic stimulus | GO:0009410 | 13 | 0.039 | |
| lipid transport | GO:0006869 | 98 | 0.039 | |
| regulation of organ growth | GO:0046620 | 61 | 0.039 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.039 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.039 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.038 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.038 | |
| response to inorganic substance | GO:0010035 | 96 | 0.038 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.037 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.037 | |
| fatty acid derivative metabolic process | GO:1901568 | 33 | 0.037 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.037 | Human |
| activation of immune response | GO:0002253 | 138 | 0.037 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.036 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.036 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.036 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.036 | |
| regulation of blood vessel size by renin angiotensin | GO:0002034 | 5 | 0.036 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.036 | |
| response to peptide | GO:1901652 | 136 | 0.035 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.035 | |
| mapk cascade | GO:0000165 | 281 | 0.035 | |
| endocrine process | GO:0050886 | 39 | 0.035 | |
| regulation of protein transport | GO:0051223 | 163 | 0.035 | |
| forebrain development | GO:0030900 | 302 | 0.034 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.033 | |
| kidney development | GO:0001822 | 213 | 0.033 | |
| heme metabolic process | GO:0042168 | 16 | 0.032 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.032 | |
| synaptic transmission | GO:0007268 | 329 | 0.031 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.031 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.031 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.031 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.031 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.031 | |
| short chain fatty acid metabolic process | GO:0046459 | 6 | 0.031 | |
| muscle tissue development | GO:0060537 | 308 | 0.031 | |
| response to oxidative stress | GO:0006979 | 123 | 0.030 | |
| regulation of system process | GO:0044057 | 200 | 0.030 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.030 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.030 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.030 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.030 | |
| primary alcohol metabolic process | GO:0034308 | 11 | 0.030 | |
| cellular homeostasis | GO:0019725 | 240 | 0.030 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.029 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.029 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.029 | |
| pyridine containing compound metabolic process | GO:0072524 | 14 | 0.029 | Human |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.029 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.029 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.028 | |
| immune effector process | GO:0002252 | 321 | 0.028 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.028 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.028 | Human |
| polyamine catabolic process | GO:0006598 | 2 | 0.028 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.028 | |
| cell cell junction organization | GO:0045216 | 72 | 0.028 | |
| hormone secretion | GO:0046879 | 128 | 0.028 | |
| response to insulin | GO:0032868 | 100 | 0.028 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.027 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.027 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.027 | |
| retinoic acid metabolic process | GO:0042573 | 12 | 0.027 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.027 | |
| tissue homeostasis | GO:0001894 | 115 | 0.026 | |
| icosanoid metabolic process | GO:0006690 | 33 | 0.026 | |
| cytokine production | GO:0001816 | 319 | 0.026 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.026 | |
| male sex differentiation | GO:0046661 | 109 | 0.026 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.026 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.026 | |
| glucose homeostasis | GO:0042593 | 128 | 0.025 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.025 | |
| estrogen secretion | GO:0035937 | 1 | 0.025 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.025 | |
| neurotransmitter catabolic process | GO:0042135 | 3 | 0.025 | |
| respiratory system development | GO:0060541 | 190 | 0.025 | |
| positive regulation of estrogen secretion | GO:2000863 | 1 | 0.025 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.025 | |
| response to retinoic acid | GO:0032526 | 56 | 0.025 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.025 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.025 | |
| female sex differentiation | GO:0046660 | 84 | 0.024 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.024 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.024 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.024 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.024 | |
| protein glycosylation | GO:0006486 | 55 | 0.024 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.024 | |
| endothelial cell migration | GO:0043542 | 44 | 0.024 | |
| epithelium migration | GO:0090132 | 63 | 0.024 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.023 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.023 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| muscle system process | GO:0003012 | 141 | 0.023 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.023 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.023 | |
| heart growth | GO:0060419 | 45 | 0.023 | |
| dna metabolic process | GO:0006259 | 303 | 0.023 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.022 | |
| gonad development | GO:0008406 | 141 | 0.022 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.022 | |
| response to estrogen | GO:0043627 | 24 | 0.022 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.022 | Rat |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.022 | |
| lipid storage | GO:0019915 | 36 | 0.022 | |
| very low density lipoprotein particle assembly | GO:0034379 | 2 | 0.022 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.022 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.022 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.022 | |
| response to peptide hormone | GO:0043434 | 127 | 0.022 | |
| glutathione metabolic process | GO:0006749 | 16 | 0.022 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.022 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.022 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.022 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.021 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.021 | |
| apical junction assembly | GO:0043297 | 15 | 0.021 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.021 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.021 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.021 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.021 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.021 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.021 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.021 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.021 | |
| stem cell differentiation | GO:0048863 | 268 | 0.021 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.021 | |
| retinol metabolic process | GO:0042572 | 9 | 0.021 | |
| female meiosis chromosome segregation | GO:0016321 | 1 | 0.020 | |
| regulation of tube size | GO:0035150 | 57 | 0.020 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.020 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.020 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.020 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.020 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.020 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.020 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.020 | |
| digestive system development | GO:0055123 | 200 | 0.019 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.019 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.019 | |
| epidermis development | GO:0008544 | 187 | 0.019 | |
| lung development | GO:0030324 | 164 | 0.019 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.019 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.019 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.019 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.019 | |
| germ cell development | GO:0007281 | 185 | 0.019 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.019 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.019 | |
| cation homeostasis | GO:0055080 | 212 | 0.019 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.019 | |
| protein maturation | GO:0051604 | 176 | 0.019 | |
| epithelial cell development | GO:0002064 | 159 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.018 | |
| response to nutrient levels | GO:0031667 | 109 | 0.018 | |
| nitrobenzene metabolic process | GO:0018916 | 1 | 0.018 | |
| cardiac chamber development | GO:0003205 | 108 | 0.018 | |
| chemotaxis | GO:0006935 | 247 | 0.018 | |
| inflammatory response | GO:0006954 | 244 | 0.018 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.018 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.018 | |
| telencephalon development | GO:0021537 | 186 | 0.018 | |
| hindbrain development | GO:0030902 | 128 | 0.018 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.018 | |
| hematopoietic stem cell migration | GO:0035701 | 1 | 0.018 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.018 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.018 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.018 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.018 | |
| neuron projection guidance | GO:0097485 | 141 | 0.018 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.018 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.018 | |
| linoleic acid metabolic process | GO:0043651 | 6 | 0.018 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.018 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.018 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.018 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.017 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.017 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.017 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.017 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.017 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.017 | |
| aldehyde catabolic process | GO:0046185 | 4 | 0.017 | |
| metencephalon development | GO:0022037 | 89 | 0.017 | |
| response to growth factor | GO:0070848 | 198 | 0.017 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.017 | |
| sensory perception | GO:0007600 | 245 | 0.017 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.017 | |
| innate immune response | GO:0045087 | 157 | 0.017 | |
| response to stilbenoid | GO:0035634 | 22 | 0.016 | |
| formaldehyde metabolic process | GO:0046292 | 1 | 0.016 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.016 | |
| cholesterol storage | GO:0010878 | 4 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.016 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.016 | |
| endocrine hormone secretion | GO:0060986 | 15 | 0.016 | |
| long chain fatty acid metabolic process | GO:0001676 | 26 | 0.016 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.016 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.016 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.016 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.016 | |
| oxygen metabolic process | GO:0072592 | 4 | 0.016 | Mouse |
| regulation of receptor activity | GO:0010469 | 41 | 0.016 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.016 | |
| regulation of complement activation | GO:0030449 | 7 | 0.015 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.015 | |
| cell junction organization | GO:0034330 | 77 | 0.015 | |
| wound healing | GO:0042060 | 157 | 0.015 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.015 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.015 | |
| transmembrane transport | GO:0055085 | 412 | 0.015 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.015 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.015 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.015 | |
| plasma membrane long chain fatty acid transport | GO:0015911 | 1 | 0.015 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.015 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.015 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.015 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.015 | |
| spermatid differentiation | GO:0048515 | 115 | 0.015 | |
| negative regulation of reproductive process | GO:2000242 | 31 | 0.015 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.015 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.015 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.015 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.015 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.015 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.015 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.015 | |
| endothelium development | GO:0003158 | 45 | 0.015 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.014 | |
| nuclear division | GO:0000280 | 158 | 0.014 | |
| regulation of ketone biosynthetic process | GO:0010566 | 2 | 0.014 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.014 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.014 | |
| regulation of ion transport | GO:0043269 | 215 | 0.014 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.014 | |
| response to hypoxia | GO:0001666 | 58 | 0.014 | |
| defense response to other organism | GO:0098542 | 197 | 0.014 | |
| nephron tubule development | GO:0072080 | 84 | 0.014 | |
| digestive tract development | GO:0048565 | 190 | 0.014 | |
| regulation of cell size | GO:0008361 | 72 | 0.014 | |
| sterol homeostasis | GO:0055092 | 45 | 0.014 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.014 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.014 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.014 | |
| regulation of chloride transport | GO:2001225 | 2 | 0.014 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.014 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.014 | |
| regulation of cell growth | GO:0001558 | 91 | 0.014 | |
| glycosylation | GO:0070085 | 62 | 0.014 | |
| regulation of defense response | GO:0031347 | 233 | 0.014 | |
| primary alcohol catabolic process | GO:0034310 | 2 | 0.014 | |
| nicotinamide nucleotide metabolic process | GO:0046496 | 12 | 0.014 | Human |
| regulation of inflammatory response | GO:0050727 | 147 | 0.014 | |
| protein oligomerization | GO:0051259 | 67 | 0.014 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.014 | |
| nephron epithelium development | GO:0072009 | 92 | 0.014 | |
| male gamete generation | GO:0048232 | 285 | 0.014 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.014 | |
| organelle fission | GO:0048285 | 170 | 0.013 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.013 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.013 | |
| mesonephros development | GO:0001823 | 97 | 0.013 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.013 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.013 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.013 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.013 | |
| positive regulation of steroid hormone secretion | GO:2000833 | 2 | 0.013 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.013 | |
| pigment metabolic process | GO:0042440 | 32 | 0.013 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.013 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.013 | |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.013 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.013 | |
| rhythmic process | GO:0048511 | 174 | 0.013 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.013 | |
| vasoconstriction | GO:0042310 | 27 | 0.013 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.013 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.013 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.013 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.013 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.013 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.013 | |
| membrane organization | GO:0061024 | 245 | 0.013 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.013 | |
| response to corticosterone | GO:0051412 | 1 | 0.013 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.013 | |
| developmental cell growth | GO:0048588 | 84 | 0.013 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.013 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.013 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.013 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.013 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.013 | |
| limbic system development | GO:0021761 | 72 | 0.013 | |
| polyol metabolic process | GO:0019751 | 26 | 0.012 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.012 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 2 | 0.012 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.012 | |
| gland development | GO:0048732 | 330 | 0.012 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.012 | |
| muscle cell development | GO:0055001 | 133 | 0.012 | |
| regulation of protein processing | GO:0070613 | 96 | 0.012 | |
| organic acid transport | GO:0015849 | 101 | 0.012 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.012 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.012 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.012 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.012 | |
| tissue remodeling | GO:0048771 | 102 | 0.012 | |
| fat cell differentiation | GO:0045444 | 160 | 0.012 | |
| regulation of heart growth | GO:0060420 | 31 | 0.012 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.012 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.012 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.012 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.012 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.012 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.012 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.012 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.012 | |
| female gonad development | GO:0008585 | 71 | 0.012 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.012 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.012 | |
| cellular biogenic amine catabolic process | GO:0042402 | 5 | 0.012 | |
| renal sodium excretion | GO:0035812 | 3 | 0.012 | |
| sodium ion export from cell | GO:0036376 | 1 | 0.012 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.012 | |
| cellular response to peptide | GO:1901653 | 92 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.012 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.012 | |
| neuromuscular process | GO:0050905 | 99 | 0.012 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.012 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.012 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.012 | |
| sphingolipid catabolic process | GO:0030149 | 7 | 0.012 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.012 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.012 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.012 | |
| lipid homeostasis | GO:0055088 | 63 | 0.012 | |
| complement activation | GO:0006956 | 16 | 0.012 | |
| neuron projection extension | GO:1990138 | 64 | 0.012 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.012 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.012 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.012 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.012 | |
| cell growth | GO:0016049 | 130 | 0.012 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.011 | |
| physiological muscle hypertrophy | GO:0003298 | 3 | 0.011 | |
| anion transport | GO:0006820 | 177 | 0.011 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.011 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.011 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.011 | |
